The FDA may require weight-loss drugs to undergo clinical trials to see if they pose a risk of heart attack.
Daily News Roundup
The FDA may require weight-loss drugs to undergo clinical trials to see if they pose a risk of heart attack.
The US Supreme Court ordered patents held by Myriad Genetics to be reviewed further by the Federal Circuit Court.
Graduate students ask for more federal research support.
Are donors of biological material privy to research results that stem from their donation?
A second advisor for the National Children’s Study resigns in response to changes in study design.
The US Supreme Court ruled that two dose calibration methods from biotech company Prometheus Laboratories cannot be patented.
A new bill recently debated in the US Congress seeks to streamline the approval process for drugs.
A selection of 40 top science policy questions that need to be addressed were selected and published by researchers last week.
Anonymous letters to The Lancet point to problems with the CDC's Center for Global Health, but the agency denies the allegations.
The Federal Research Public Access Act faces stiff opposition from the Association American of Publishers.